相关实验视频

Updated: May 2, 2026

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

SPARC:一个基于信号触发的,自供应的crRNA和分层PER-转录-CRISPR级联的可编程分子诊断平台,用于早期检测肝细胞癌

Xinying Chang¹, Cong Han¹, Haishuo Ji¹

¹State Key Laboratory of Medicinal Chemical Biology, Nankai International Advanced Research Institute (Shenzhen Futian), College of Life Sciences, Nankai University, Tianjin, 300350, PR China.

Analytica chimica acta

|February 23, 2026

概括

我们开发了SPARC,这是一个用于超敏感微RNA (miRNA) 检测的新平台,可用于早期癌症查. 这项技术为临床应用提供了高特异性和稳定性.

科学领域:

生物技术是生物技术.
分子诊断学分子诊断
基因组学就是基因组学.

背景情况:

准确的微RNA (miRNA) 量化对于早期癌症检测至关重要,但在灵敏度,特异性和强度方面面临挑战.
现有的miRNA检测试验往往无法满足临床要求.

研究的目的:

为微RNA检测开发一个高度敏感和特定的平台.
创建一个强大的和临床兼容的分子诊断系统.

主要方法:

介绍SPARC,一个可编程分子诊断平台.
集成信号触发的原始交换反应,自供应的crRNA生成,以及分层的PER-转录-CRISPR/Cas12a放大级联.
使用miRNA-21作为绩效评估的模型.

主要成果:

对于miRNA-21,SPARC实现了1.22 fM的超低检测极限,具有广泛的定量范围 (1 fM至100 nM).
证明了高特异性,分析稳定性和对各种miRNA目标的模块化适应性.
精确区分恶性与正常的HCC样本,显示与qRT-PCR和组织病理学一致.

结论:

SPARC是一种精简的,自我放大级联系统,用于超敏感的miRNA检测.
该平台具有可扩展性,稳健性和临床兼容性,适用于早期肝细胞癌查.
SPARC显示了分子亚型和精密瘤学应用的潜力.

关键词:

这就是CRISPR/Cas12a.肝细胞癌是肝细胞癌.异热放大器的同热放大方式原料交换反应的原料交换反应检测miRNA检测的方法

更多相关视频

Field-Deployable Candidatus Liberibacter asiaticus Detection Using Recombinase Polymerase Amplification Combined with CRISPR-Cas12a

Field-Deployable Candidatus Liberibacter asiaticus Detection Using Recombinase Polymerase Amplification Combined with CRISPR-Cas12a

Published on: December 23, 2022

Author Spotlight: Engineering Molecular Tools for Disease Detection and Imaging

Author Spotlight: Engineering Molecular Tools for Disease Detection and Imaging

Published on: December 8, 2023

相关概念视频

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...